{
    "id": "44373278",
    "text": "Daniele Piomelli is an Italian-born American scientist. He studied neuroscience in New York City, with James H. Schwartz and Eric R. Kandel at Columbia University College of Physicians and Surgeons (PhD, 1983-1988) and later with Paul Greengard at the Rockefeller University (Post-doc, 1988-1990). Two of his mentors (Kandel and Greengard) received in 2000 the Nobel Prize for their contributions to medicine. After working at the INSERM in Paris (1990-1995) and at the Neurosciences Institute in La Jolla (1995-1998) with Nobel Prize winner Gerald Edelman, he joined the University of California Irvine School of Medicine, where he is now Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology and Biological Chemistry. He is also founding director of the department of Drug Discovery and Development (D3) at the Istituto Italiano di Tecnologia in Genova, Italy. Piomelli has made important contributions to the understanding of lipid mediator function in the brain and nervous system. He elucidated the biochemical pathways involved in the formation and deactivation of the lipid- derived endocannabinoids \u2013 anandamideDi Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994). \u201cFormation and inactivation of endogenous cannabinoid anandamide in central neurons\u201d. Nature 372 (6507): 686-91. . and 2-arachidonoylglycerol Stella N, Schweitzer P, Piomelli, D (1997). \u201cA second endogenous cannabinoid that modulates long-term potentiation\u201d. Nature 388 (6644): 773-8. . \u2013 and uncovered various physiological roles played by these compounds.Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999). \u201cDopamine activation of endogenous cannabinoid signaling in dorsal striatum\u201d. Nature Neuroscience 2 (4): 358-63. .Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D (2000). \u201cBidirectional control of airway responsiveness by endogenous cannabinoids\u201d. Nature 408 (6808): 96-101. .Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005). \u201cAn endocannabinoid mechanism for stress-induced analgesia\u201d. Nature 435 (7045): 1108-12. .Clapper JR, Moreno-Sanz G, Russo R, Guijarro A, Vacondio F, Duranti A, Tontini A, Sanchini S, Sciolino NR, Spradley JM, Hohmann AG, Calignano A, Mor M, Tarzia G, Piomelli D (2010). \u201cAnandamide suppresses pain initiation through a peripheral endocannabinoid mechanism\u201d. Nature Neuroscience 13 (10): 1265-70. .DiPatrizio NV, Astarita G, Schwartz GJ, Li X, Piomelli D (2011) \u201cEndocannabinoid signal in the gut controls dietary fat intake\u201d. Proceedings of the National Academy of Sciences USA 108 (31): 12904-8. .Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H, Ginger M, Frick A, DiPatrizio NV, Mackie K, Katona I, Piomellli D, Manzoni OJ (2013) \u201cUncoupling of the endocannabinoid signaling complex in a mouse model of fragile X syndrome\u201d. Nature Communications 3 (1080). . Additionally, he described the functions of two lipid amides \u2013palmitoylethanolamide (PEA) and oleoylethanolamide \u2013 in the control of pain Calignano A, La Rana G, Makriyannis A, Lin SY, Beltramo M, Piomelli D (1998) \u201cControl of pain initiation by endogenous cannabinoids\u201d. Nature 394 (6690): 277-81. . and feeding,Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, Lo Verme J, Gaetani S, Kathuria S, Gall C, Piomelli D (2001) \u201cAn anorexic lipid mediator regulated by feeding\u201d. Nature 414 (6860): 209-12. .Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez de Fonseca F, Rosengarth A, Lueke H, Di Giacomo B, Tarzia G, Piomelli D (2003) \u201cOleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha\u201d. Nature 425 (6953): 90-3. .Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, Campolongo P, Cuomo V, Piomelli D (2008) \u201cThe lipid messenger OEA links dietary fat intake to satiety\u201d Cell Metabolism 8 (4): 281-8. . and identified the cellular receptors involved in such functions.Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez de Fonseca F, Rosengarth A, Lueke H, Di Giacomo B, Tarzia G, Piomelli D (2003) \u201cOleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha\u201d. Nature 425 (6953): 90-3. .Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D (2005) \u201cThe nuclear receptor peroxisome proliferator-activated receptor- alpha mediates the anti-inflammatory actions of palmitoylethanolamide\u201d. Molecular Pharmacology 67 (1): 15-9. . Collaborating with Italian chemists, Giorgio Tarzia (University of Urbino \u2018Carlo Bo\u2019) and Marco Mor (University of Parma), he developed the first systemically active inhibitors of the degradation of anandamide (Fatty Acid Amide Hydrolase inhibitors),Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D (2003) \u201cModulation of anxiety through blockade of anandamide hydrolysis\u201d. Nature Medicine 9 (1): 76-81. .Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2006) \u201cAntidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis\u201d. Proceedings of the National Academy of Sciences USA 103 (7): 24665. . PEA (N-Acylethanolamide Acid Amidase inhibitors),Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S, Mor M, Russo R, Maccarrone M, Antonietti F, Duranti A, Tontini A, Cuzzocrea S, Tarzia G, Piomelli D (2009) \u201cSelective N-acylethanolamine- hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation\u201d. Proceedings of the National Academy of Sciences USA 106 (49): 20966-71. . and ceramide (Acid Ceramidase inhibitors).Realini N, Solorzano C, Pagliuca C, Pizzirani D, Armirotti A, Luciani R, Costi MP, Bandiera T, Piomelli D (2013) \u201cDiscovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity\u201d. Science Reports 3:1035. . Daniele Piomelli is scientific cofounder of Kadmus Pharmaceuticals and Thesan Pharmaceuticals. == References == == External links == * Laboratory webpage * Neurotree Category:Year of birth missing (living people) Category:Living people Category:American neuroscientists Category:Columbia University College of Physicians and Surgeons alumni Category:University of California, Irvine faculty ",
    "title": "Daniele Piomelli"
}